Get started
Author

Henrik Nordin

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry
2017 · Bente Glintborg, Inge Juul Sørensen, et al. · Annals of the Rheumatic Diseases · 251
Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry
2013 · Bente Glintborg, Mikkel Østergaard, et al. · Arthritis & Rheumatism · 205
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry
2012 · Lene Dreyer, Lene Mellemkjær, et al. · Annals of the Rheumatic Diseases · 184
PDF
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry
2018 · Bente Glintborg, Anne Gitte Loft, et al. · Annals of the Rheumatic Diseases · 152
PDF
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
2012 · Bente Glintborg, Mikkel Østergaard, et al. · Annals of the Rheumatic Diseases · 149
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry
2017 · Else Helene Ibfelt, Jan Sørensen, et al. · Clinical Epidemiology · 94
PDF
Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician’s Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry
2015 · Cecilie Lindström Egholm, Niels Steen Krogh, et al. · The Journal of Rheumatology · 80
Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry
2015 · Bente Glintborg, Pil Højgaard, et al. · Rheumatology · 76
Microalbuminuria in patients with rheumatoid arthritis.
1995 · L.M. Pedersen, H Nordin, et al. · Annals of the Rheumatic Diseases · 72
PDF
Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry
2016 · Bente Glintborg, Inge J. Sørensen, et al. · The Journal of Rheumatology · 59
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO
2014 · B. Glintborg, B. Gudbjornsson, et al. · Rheumatology · 38
Familial occurrence of eccrine tumours in a family with ectodermal dysplasia.
1988 · H Nordin, T Månsson, et al. · PubMed · 26
FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry
2017 · B Glintborg, IJ Sørensen, et al. · Annals of the Rheumatic Diseases · 23
PDF
One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept:an Observational Study from the Danish Danbio Registry
2017 · Glintborg, Bente, Omerovic, Emina, et al. · University of Southern Denmark Research Portal (University of Southern Denmark) · 15
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
2018 · B Glintborg, T Kringelbach, et al. · Scandinavian Journal of Rheumatology · 12
[Microalbuminuria in rheumatoid arthritis].
1996 · H Nordin, L M Pedersen, et al. · PubMed · 10
Cardiac performance and thyroid function. The correlation between systolic time intervals, heart rate and thyroid hormone levels.
1993 · A M Galløe, M Rolff, et al. · PubMed · 10
Captopril and Resistant Ascites
1983 · Frank Jørgensen, Jørn Badskjaer, et al. · The Lancet · 10
Non-Hodgkin malignant lymphoma in the nails in the course of a chronic lymphocytic leukaemia.
1992 · L M Pedersen, H Nordin, et al. · Acta Dermato Venereologica · 6
PDF
OP0225 Three Months' Clinical Outcomes from A Nationwide Non-Medical Switch from Originator To Biosimilar Infliximab in Patients with Inflammatory Arthritis. Results from The Danbio Registry
2016 · B. Glintborg, I. Juul Sørensen, et al. · Annals of the Rheumatic Diseases · 5
Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching’ by Cantini and Benucci
2018 · Bente Glintborg, Anne Gitte Loft, et al. · Annals of the Rheumatic Diseases · 4
FRI0103 One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study
2018 · B. Glintborg, I.J. Sørensen, et al. · Annals of the Rheumatic Diseases · 4
PDF
OP0168 Clinical response, drug survival and predictors thereof in 432 patients with ankylosing spondylitis switching anti tumor necrosis factor α therapy: Results from the danish nationwide danbio registry
2012 · B. Glintborg, M. Østergaard, et al. · Annals of the Rheumatic Diseases · 4
[Kidney function problems in rheumatoid arthritis].
1996 · H Nordin, L M Pedersen · PubMed · 2
[Polycythemia vera in a Danish family].
1991 · H Nielsen, H Nordin · PubMed · 2
Works count: 47
Citation count: 1,500
H-index: 14
I10-index: 18
Year
Topic
Type